Quarterly report [Sections 13 or 15(d)]

Unaudited Consolidated Statements of Operations

v3.26.1
Unaudited Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Other revenue $ 0 $ 1,404 $ 0 $ 1,404
Operating expenses:        
Research and development 247 192 447 603
General and administrative 460 915 974 2,408
Total operating expenses 707 1,107 1,421 3,011
Income (loss) from operations (707) 297 (1,421) (1,607)
Other income:        
Interest income 17 31 35 62
Change in fair value of warrant liabilities 0 1 1 16
Total other income 17 32 36 78
Net income (loss) (690) 329 (1,385) (1,529)
Net loss attributable to non-controlling interests 0 (6) 0 (12)
Net income (loss) attributable to Avenue (690) 335 (1,385) (1,517)
Net income (loss) attributable to common stockholders $ (690) $ 335 $ (1,385) $ (1,517)
Net income (loss) per common share attributable to common stockholders, basic and diluted (in dollars per share) $ (0.21) $ 0.11 $ (0.42) $ (0.49)
Weighted average number of common shares outstanding, basic and diluted (in shares) 3,294,967 3,183,558 3,294,351 3,077,704